News
| News article on GenPhar vaccines published in Post & Courier newspaper | 2009-06-15 | |
| Vaccine 'effective' against dengue Researchers, Navy plan to begin human trials By Prentiss Findlay The Post and Courier Monday, June 15, 2009 |
||
 |
||
| GenPhar to begin manufacture of its tetravalent dengue vaccine for Phase I clinical trials | 2009-06-05 | |
| US Navy and GenPhar working together to conduct Phase I clinical trial to fight fatal disease caused by all serotypes of dengue viruses. Mount Pleasant, South Carolina, United States of America, June 5, 2009 |
||
|
||
| GenPhar to present at ASGT American Society of Gene Therapy, 12th Annual Meeting, | 2009-05-27 | |
| ASGT American Society of Gene Therapy, 12th Annual Meeting, "Gene Transfer: It's promise, concerns, and now its application" San Diego, California, May 27 – May 30, 2009 | ||
|
||
| GenPhar Appoints Dr. Ken Wang as Manager of Process Development | 2009-05-18 | |
| Mount Pleasant, South Carolina, United States of America, May 18, 2009 | ||
|
||
| Dr. John Dong to present at the 7th Annual Biodefense Vaccines and Therapeutics Conference. | 2009-04-24 | |
| July 15-17th, 2009, Almas Temple Club, Washington, DC. Leading Decision Makers Provide a Briefing On the New Administration's Initiatives On Biodefense Vaccines and Therapeutics |
||
|
||
| GenPhar presents at 2nd International Conference on Dengue and Dengue Haemorrhagic Fever, Phuket Thailand | 2008-10-15 | |
| 2nd International Conference on Dengue and Dengue Haemorrhagic Fever, Global Innovation to Fight Dengue Oct 15-17th, Hilton Phuket Arcadia Resort & Spa in Phuket Thailand |
||
|
||
| GenPhar at HHS Public Health Emergency Medical Countermeasures Enterprise Stakeholders Workshop 2008 and BARDA Industry Day | 2008-09-24 | |
| HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2008 and BARDA Industry Day September 24-26th, Crystal Gateway Marriott, Arlington, VA |
||
|
||
| GenPhar Enters Agreement with the United States Naval Medical Research Center to bring GenPhar’s dengue vaccine into Phase I clinical trials | 2008-09-24 | |
| Contract agreement for tetravalent dengue vaccine to fight fatal disease. Mount Pleasant, South Carolina, United States of America, September 24, 2008 |
||
|
||
| John Dong presents at the 2008 International Society for Cell and Gene Therapy of Cancer Congress | 2008-09-19 | |
| 2008 International Society for Cell and Gene Therapy of Cancer (ISCGT) Congress September 19-22, Shijiazhuang, People's Republic of China |
||
|
||
| John Dong chairs SMi's 4th Biannnual Vaccines Summit 2008 in London, England | 2008-06-16 | |
| SMi hold their 4th Biannual Vaccines Summit, bringing together the key players of the vaccine industry to work towards saving and enhancing lives. John Dong chairs this event and presents data on the GenPhar CAdVax technology. |
||
|
||
| GenPhar's vaccine technology well received at 6th Annual Biodefense Vaccines & Therapeutics conference | 2008-06-09 | |
| 6th Annual Biodefense Vaccines & Therapeutics conference June 9-11 The Almas Temple in Washington, DC. |
||
|
||
| Key lecture given by John Dong at Phacilitate Vaccine Forum, Geneva Switzerland | 2008-05-01 | |
| Phacilitate Vaccine Forum Geneva 2008 May 14-16 The Hotel Président Wilson |
||
|
||
| John Dong presents at Dengue Vaccine Scientific Forum | 2008-04-01 | |
|
||
| US Army Medical Research Institute of Infectious Diseases (USAMRIID) to publish the success of the first multivalent Ebola and Marburg virus (pan-filo) vaccine developed with GenPhar, Inc. | 2008-03-04 | |
| Multivalent pan-filovirus vaccine shows 100% efficacy against all relevant virus strains | ||
|
||
| Congress has approved $3 million to supplement GenPhar and U.S. Navy collaboration on developing multivalent dengue vaccine | 2008-03-04 | |
| Defense Appropriations approved for FY2008 | ||
|
||
| U.S. Naval Medical Research Center has committed to conduct the clinical trials of a tetravalent dengue vaccine jointly developed by GenPhar and NMRC | 2008-02-27 | |
| Filing with FDA for clinical trials is expected later this year | ||
|
||
| GenPhar to build South Carolina’s first vaccine production facility | 2008-02-22 | |
| Construction is underway for 50,000 ft2 GMP facility | ||
|
||
| Tropical dengue fever may threaten U.S.: report | 2008-01-09 | |
| WASHINGTON, Jan 8 (Reuters) - Dengue fever -- a tropical infection that usually causes flu-like illness -- may be poised to spread across the United States and urgent study is needed, health officials said on Tuesday. | ||
|
||
| GenPhar to break ground at Innovation Park on August 31 | 2007-08-30 | |
| The Town of Mount Pleasant and the Mount Pleasant Office of Economic Development are pleased to announce the groundbreaking ceremony of GenPhar, Inc., a biopharmaceutical company, on Friday, August 31 at 10:00 AM. | ||
|
||
| GenPhar facility design approved! Press conference to announce project | 2007-03-05 | |
|
||
| GenPhar partners with ImmuneRegen for avian flu vaccine | 2007-01-18 | |
| Genphar, Inc begins research partnership with ImmuneRegen, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (BULLETIN BOARD: IRBO). | ||
|
||
| GenPhar's dengue vaccine demonstrates 100% efficacy and safety | 2006-11-09 | |
| Tetravalent dengue vaccine shows impressive results after stringent testing. | ||
|
||
| GenPhar awarded $4 Million grant from National Institutes of Health | 2006-09-12 | |
| NIH awarded GenPhar $4M to bring its trivalent Marburg vaccine into clinical development. | ||
|
||
| GenPhar biodefense vaccines featured in Business section of Post and Courier newspaper | 2006-08-06 | |
| GenPhar’s biodefense vaccines capture media attention and are featured in the article, “Firm at the forefront of bioterrorism fight.” The article highlights the socio-economic impact that GenPhar's Ebola, Marburg and other biodefense vaccines will have at the local, national and international level. | ||
|
||
| GenPhar holds pre-IND meeting for Ebola vaccine | 2006-05-15 | |
| GenPhar held a pre-IND meeting for its Ebola vaccine May 12, 2006. The meeting with the FDA was successful and the company continues the drive towards human safety trials. GenPhar plans to file its Marburg vaccine in succession of the Ebola vaccine trials. | ||
|
||
| GenPhar featured on WCIV ABC news | 2006-03-21 | |
| GenPhar’s successful data from USAMRIID challenge experiments and contract extension with NMRC attracted local media attention. GenPhar was featured on four separate newscasts that focused on the company's biodefense Ebola, Marburg and avain flu vaccine programs. | ||
|
||
| GenPhar’s R&D contract with NMRC extended | 2006-02-06 | |
| Charleston Regional Business Journal features GenPhar in the article: Mount Pleasant-based biopharmaceutical helping in war effort. | ||
|
||
| Lowcountry gets share of appropriations bill | 2003-10-11 | |
| Brooke J. Weese, Special to The Packet | ||
|
||
| Hollings Announces Committee Approval of SC Defense Funding | 2003-07-09 | |
| Hollings secures funding for procurement and R&D projects in South Carolina | ||
|
||
| GenPhar's Vaccine Platform Yields Promising Results for Biowarfare Defense | 2002-10-07 | |
| Vaccine for Marburg Virus Is 100 Percent Effective in U.S. Army Animal Trials | ||
|
||
| GenPhar Unveils Breakthrough Technology Platforms and Biopharmaceutical Products Including Promising | 2002-04-01 | |
| GenPhar Founded in 1999 by Leading Scientists; Received More Than $8 Million | ||
|
||
| GenPhar Announces Novel Vaccines for HIV, Hepatitis B, Hepatitis C, and Marburg Viruses | 2002-04-01 | |
| GenPhar Partners with NIH and U.S. Army to Pursue Animal Trials of Vaccines | ||
|
||
print this page
contact us
site map